documents: FDA-2026-N-1832-0016

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-N-1832-0016 FDA FDA-2026-N-1832 GRAS Notice (GRN) 1294 – Rebaudioside M produced by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni – amendments Notice General Notice 2026-05-19T04:00:00Z 2026 5 2026-05-19T04:00:00Z   2026-05-19T22:46:40Z   0 0 09000064b92e1248

Links from other tables